Package 66658-230-01

Brand: synagis

Generic: palivizumab
NDC Package

Package Facts

Identity

Package NDC 66658-230-01
Digits Only 6665823001
Product NDC 66658-230
Product ID 66658-230_48e6af70-cd93-3f1d-e063-6394a90a8104
Description

.5 mL in 1 VIAL, SINGLE-DOSE (66658-230-01)

Marketing

Marketing Status
Discontinued 2026-09-30
Brand synagis
Generic palivizumab
Sample Package No

Linked Drug Pages (1)

Synagis ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR"], "spl_id": "48e6af70-cd93-3f1d-e063-6394a90a8104", "openfda": {"nui": ["M0001357", "N0000175615", "N0000175623"], "upc": ["0366658231013"], "unii": ["DQ448MW7KS"], "rxcui": ["1657341", "1657343", "1657361", "1657362"], "spl_set_id": ["3a0096c7-8139-44cd-bba4-520ab05c2cb2"], "pharm_class_cs": ["Antibodies, Monoclonal [CS]"], "pharm_class_epc": ["Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]"], "pharm_class_moa": ["Fusion Protein Inhibitors [MoA]"], "manufacturer_name": ["Swedish Orphan Biovitrum AB (publ)"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": ".5 mL in 1 VIAL, SINGLE-DOSE (66658-230-01)", "package_ndc": "66658-230-01", "marketing_end_date": "20260930", "marketing_start_date": "20050928"}], "brand_name": "Synagis", "product_id": "66658-230_48e6af70-cd93-3f1d-e063-6394a90a8104", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Antibodies", "Monoclonal [CS]", "Fusion Protein Inhibitors [MoA]", "Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]"], "product_ndc": "66658-230", "generic_name": "palivizumab", "labeler_name": "Swedish Orphan Biovitrum AB (publ)", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Synagis", "active_ingredients": [{"name": "PALIVIZUMAB", "strength": "50 mg/.5mL"}], "application_number": "BLA103770", "marketing_category": "BLA", "marketing_end_date": "20260930", "marketing_start_date": "19991209"}